Description

VONOBRITE HP KIT: Vonoprazan, Clarithromycin & Amoxycillin Combikit

VONOBRITE HP KIT is a co-packaged prescription combination containing vonoprazan 20 mg tablets, clarithromycin 500 mg tablets and amoxycillin 500 mg capsules. The 1×14 kit is designed to organize the medicines used in a clinician-selected triple-therapy regimen for the eradication of Helicobacter pylori in adults. Intra Life lists the product under its Gastro Advance (Speciality) range.

The combination brings together a potassium-competitive acid blocker, or P-CAB, with two antibacterial medicines. It is intended only for use on the prescription and under the supervision of a registered medical practitioner. Selection of any clarithromycin-containing regimen should reflect the patient’s history, local treatment guidance and the likelihood or confirmation of clarithromycin susceptibility because antibiotic resistance can reduce treatment success.

Product Overview

What Is VONOBRITE HP KIT Used For?

VONOBRITE HP KIT is indicated on Intra Life’s official product page for the *eradication of Helicobacter pylori infection*, particularly where the infection is associated with peptic ulcer disease, gastritis, gastric ulcer or duodenal ulcer.[1] The treating clinician must decide whether this combination is appropriate for an individual patient.

H. pylori is a bacterium that colonizes the stomach and is associated with chronic gastritis and peptic ulcer disease. Eradication treatment combines acid suppression with antibiotics. The acid blocker helps create a gastric environment in which the antibacterial components can act, while clarithromycin and amoxycillin target the organism through different antibacterial mechanisms.

Because VONOBRITE HP KIT contains two antibiotics, it should not be promoted or used as a general acidity product. It is not intended for self-medication, occasional heartburn or undiagnosed abdominal symptoms.

How the Three Components Work Together

Vonoprazan: Potassium-Competitive Acid Blocker

Vonoprazan is a potassium-competitive acid blocker (P-CAB). It suppresses gastric acid by inhibiting the hydrogen-potassium adenosine triphosphatase enzyme system in gastric parietal cells. Its mechanism differs from that of conventional proton pump inhibitors because it competes at the potassium-binding site and does not require acid activation.

Clarithromycin: Macrolide Antibacterial

Clarithromycin is a macrolide antibacterial medicine. It acts by binding to the bacterial 50S ribosomal subunit and inhibiting protein synthesis. Resistance to clarithromycin is clinically important and can substantially reduce the success of a clarithromycin-containing eradication regimen. Current guidance therefore emphasizes careful regimen selection rather than routine or indiscriminate antibiotic use.

Amoxycillin: Penicillin-Class Antibacterial

Amoxycillin, also commonly spelled amoxicillin, is a penicillin-class antibacterial medicine. It interferes with bacterial cell-wall synthesis. A documented history of serious hypersensitivity to penicillins or related beta-lactam antibiotics requires careful clinical assessment, and this combination must not be used in a patient for whom the amoxycillin component is contraindicated

Pack Presentation Designed for an Organized Course

Each VONOBRITE HP KIT contains the official listed composition of two vonoprazan 20 mg tablets, two clarithromycin 500 mg tablets and four amoxycillin 500 mg capsules, with a listed packing of 1×14 kit.[1] The pack presentation helps keep the combination together and may make the prescribed course easier to understand.

An internationally approved label for the same three active ingredients describes a 14-day adult regimen in which vonoprazan 20 mg, amoxicillin 1,000 mg and clarithromycin 500 mg are each administered twice daily. The local approved prescribing information for VONOBRITE HP KIT and the treating clinician’s directions must take precedence. Patients must not change the dose, timing, duration or combination on their own.

Responsible Use and Antibiotic Stewardship

Successful H. pylori management depends on selecting an appropriate regimen and completing it as prescribed. Previous macrolide exposure, treatment history, allergy status, clinically important interactions and regional resistance patterns may influence the clinician’s choice.

India’s Bhubaneswar Consensus from the Indian Society of Gastroenterology notes increasing resistance to clarithromycin and metronidazole and the resulting reduction in the efficacy of older proton-pump-inhibitor-based triple therapies. More recent American College of Gastroenterology guidance also advises against empiric clarithromycin-based therapy when susceptibility is unknown and stresses confirmation of eradication after treatment. These references support careful clinical selection; they are not a substitute for the locally approved product information or individual medical judgment.

Test of Cure Matters

Symptom improvement alone does not prove that H. pylori has been eradicated. The 2024 American College of Gastroenterology guideline emphasizes confirmation with a urea breath test, stool antigen test or biopsy-based test. It advises testing at least four weeks after antibiotic treatment and after acid-suppressing therapy has been withheld for the recommended period under medical direction.

This follow-up information should be presented as clinician-guided education, not as a consumer instruction to stop prescribed treatment without supervision.

Safety Information

VONOBRITE HP KIT is a prescription-only medicine. The following summary is not exhaustive and does not replace the approved package insert.

People with a known hypersensitivity to vonoprazan, clarithromycin, macrolides, amoxycillin, penicillins or related beta-lactam antibiotics require medical assessment before use. The combination may also be unsuitable in certain patients with a history of significant cardiac rhythm disorders, liver problems linked to prior clarithromycin use, severe renal or hepatic impairment, or clinically important electrolyte abnormalities.

The three components can interact with other medicines. Particularly important examples include some medicines for abnormal heart rhythm, cholesterol, migraine, transplantation, blood thinning, seizures and certain antiviral conditions. Vonoprazan is contraindicated with rilpivirine-containing products in the cited FDA label, and clarithromycin has multiple clinically important drug interactions. A prescriber or pharmacist should review the patient’s full medicine list before treatment begins.

Commonly reported effects with this type of combination may include altered taste, nausea, diarrhoea, abdominal discomfort and headache. Urgent medical attention is required for breathing difficulty, swelling, severe rash, fainting, palpitations, jaundice, or severe, persistent or bloody diarrhoea. Suspected adverse events should be reported through the appropriate pharmacovigilance channel and to the company using its published contact details.

Use during pregnancy, breastfeeding, childhood, or in significant kidney or liver impairment requires individualized medical assessment. Do not make a broad “safe in pregnancy” or “safe for children” claim on this page.

Storage and Handling

Store the product exactly as stated on the approved carton and package insert. Keep it protected from excessive heat, light and moisture, retain it in the original packaging until use, and keep it out of the sight and reach of children. Do not use a pack after its expiry date or if the blister is damaged.

VONOBRITE HP KIT for PCD Pharma Franchise in India

Intra Life invites enquiries from eligible pharmaceutical distributors, wholesalers, chemists, hospitals and healthcare entrepreneurs for its gastroenterology portfolio. VONOBRITE HP KIT can be positioned within a focused Gastro Advance PCD pharma franchise offering, subject to current territory availability and Intra Life’s commercial terms.

Intra Life’s official company profile describes a portfolio of more than 3,500 formulations and a presence across 41 divisions. The company lists offices and distribution points in Bengaluru, Ghaziabad and Kolkata.[2] These company-level credentials should be supported on the live page with links to the corporate profile, licences and quality documentation rather than repeated as unsupported badges.

Potential partners can enquire about:

• Territory availability and monopoly-based PCD franchise terms
• Current trade price, minimum order quantity and dispatch schedule
• Product literature and visual-aid support
• Distributor, hospital and institutional supply
• Current quality and regulatory documents available for the batch or product

Franchise enquiry: WhatsApp +91 90350 39420 with your name, city or district, business type, valid drug-licence status and expected quantity.

Third-Party Pharmaceutical Manufacturing Enquiries

Intra Life publicly offers third-party pharmaceutical manufacturing services through its Baddi operations. Availability of this exact composition under a customer-owned brand should not be assumed. Interested businesses should request a feasibility review covering the proposed brand name, composition, pack configuration, minimum order quantity, artwork, regulatory documents, quality agreement and commercial terms.

Use the following CTA on the page:

Why Partner with Intra Life?

Specialized gastro portfolio. VONOBRITE HP KIT belongs to the Gastro Advance (Speciality) division, allowing it to sit within a broader product range for gastroenterology-focused partners.

Established operating footprint. Intra Life’s official profile states that the business was established in 1981 and today operates a multi-location distribution network.

Broad product access. The company reports more than 3,500 formulations across 41 divisions, which may help eligible partners build multi-therapy portfolios through one organization.

Business support. Intra Life promotes PCD franchise opportunities, territory enquiries and product-list access through its official website and WhatsApp channel.

Frequently Asked Questions

What is VONOBRITE HP KIT?

VONOBRITE HP KIT is an Intra Life prescription combikit containing vonoprazan, clarithromycin and amoxycillin. It is listed in a 1×14 kit presentation under the company’s Gastro Advance (Speciality) division.

What is the composition of VONOBRITE HP KIT?

The official product page lists two tablets of vonoprazan 20 mg, two tablets of clarithromycin IP 500 mg and four capsules of amoxycillin IP 500 mg in each kit/day pack, with a 1×14 kit presentation.

What is VONOBRITE HP KIT used for?

It is listed for the eradication of Helicobacter pylori infection, including infection associated with peptic ulcer disease, gastritis, gastric ulcer or duodenal ulcer. It must be prescribed after appropriate clinical evaluation.

Is VONOBRITE HP KIT an acidity medicine?

No. Although vonoprazan suppresses gastric acid, the kit also contains two prescription antibiotics. It is intended for clinician-selected H. pylori eradication therapy, not for routine acidity or self-treatment.

How is vonoprazan different from a proton pump inhibitor?

Vonoprazan is a potassium-competitive acid blocker. It inhibits gastric acid secretion through a mechanism that differs from conventional proton pump inhibitors. The clinical choice between regimens depends on the diagnosis, treatment history, susceptibility patterns and the prescribing clinician’s judgment.

Can this clarithromycin-containing kit be used when resistance is unknown?

The prescribing clinician should consider local guidance, prior macrolide exposure and susceptibility information when available. Major guidelines caution that clarithromycin resistance can reduce eradication success and discourage indiscriminate empiric use of clarithromycin-based regimens.[3] [5]

Can a patient with penicillin allergy use VONOBRITE HP KIT?

The kit contains amoxycillin, a penicillin-class antibacterial. A patient with a known penicillin or beta-lactam allergy must inform the prescriber and must not self-administer the product.

Does VONOBRITE HP KIT interact with other medicines?

Potentially, yes. Clarithromycin and vonoprazan can have clinically important drug interactions. A healthcare professional should review all prescription medicines, over-the-counter products and supplements before treatment.

What are the common side effects?

Effects reported with the components may include altered taste, nausea, diarrhoea, abdominal discomfort and headache. Severe allergy, significant rash, jaundice, abnormal heartbeat symptoms or persistent or bloody diarrhoea require urgent medical attention.

How is successful H. pylori eradication confirmed?

Guidelines recommend a test of cure rather than relying only on symptom relief. A clinician may use a urea breath test, stool antigen test or biopsy-based test at an appropriate interval after therapy.

Is VONOBRITE HP KIT available for PCD pharma franchise?

Intra Life accepts PCD franchise enquiries for its product portfolio. Availability of VONOBRITE HP KIT and monopoly rights depends on territory, stock and company approval. Contact the official franchise WhatsApp number, +91 90350 39420.

Is VONOBRITE HP KIT available for wholesale or distribution?

Eligible distributors, wholesalers, hospitals and trade partners can submit an enquiry. Supply is subject to stock, commercial terms and valid drug-licence and tax documentation.

Is third-party manufacturing available for this composition?

Intra Life offers third-party pharmaceutical manufacturing services, but the availability of this exact formulation and pack must be confirmed through a technical and commercial feasibility review.

What is the VONOBRITE HP KIT price?

Request the current MRP, PTR, PTS and institutional or distributor terms directly from Intra Life. Do not publish an estimated or outdated price.

Who markets VONOBRITE HP KIT?

VONOBRITE HP KIT appears on the official product catalogue of Intra Life Private Limited. The company’s published corporate office is in Bengaluru, Karnataka

Keywords